-
Signature
-
/s/ John Leaman, M.D. as attorney-in-fact
-
Stock symbol
-
IMPL
-
Transactions as of
-
Apr 22, 2021
-
Transactions value $
-
$0
-
Form type
-
3/A - Amendment
-
Date filed
-
6/22/2021, 05:41 PM
-
Date Of Original Report
-
Apr 22, 2021
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
holding |
IMPL |
Series A-2 Preferred Stock |
|
|
|
|
|
|
Apr 22, 2021 |
Common Stock |
7.36K |
|
Direct |
F1 |
holding |
IMPL |
Series C-1 Preferred Stock |
|
|
|
|
|
|
Apr 22, 2021 |
Common Stock |
8.79K |
|
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
This amended Form 3 is being filed to report the omission of the Series A-2 preferred stock warrant and the Series C-1 preferred stock warrant reported on Table II in the Form 3 filed on April 22, 2021 as the warrants were exercised prior to the filing of the Form 3, and to increase the number of shares underlying the derivative security to reflect the earlier exercise of each respective warrant.